IPIC Message Board - Msg: 1962276

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : IPIC

IPIC 0.0001000

+899.9%

Aug 15 3:35 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Graham Marshman who wrote (555)	8/13/1997 11:45:00 AM
From: Graham Marshman	of 1359

Re Redux revenues, following is extract from AHP 2Q results and news commentary showing increased sales of Redux. This should show up next quarter for IPIC. Anyone know the incantation to convert this to IPIC revenue? "Worldwide pharmaceutical sales increased 9% for the 1997 second quarter and 8% for the first half due primarily to higher sales of Premarin products, Effexor, Cordarone and Zoton offset, in part, by lower sales of other pharmaceutical products. Worldwide pharmaceutical results for the 1997 second quarter also reflect higher sales of oral contraceptives while results for the first half reflect higher sales of Redux (introduced in the 1996 second quarter) and Lodine. Worldwide pharmaceutical sales were impacted by unfavorable foreign exchange effects of 2% for both the 1997 second quarter and first half." "American Home's world-wide pharmaceutical sales rose 9% on a pro forma basis in the second quarter. Sales of Premarin products rose 45% to $291.5 million in the quarter. Sales of obesity treatment Redux, which was introduced during the year-earlier quarter, totaled $42.4 million in the quarter." Graham

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next